Cough and its importance in COPD

Patients with COPD most frequently complain of breathlessness and cough and these are both increased during exacerbations. Studies have generally focused on quality of life during end-stage disease, where breathlessness becomes dominant and cough less important. There are very little data on the frequency and severity of cough in COPD or its impact on quality of life at different stages of disease. Little is known about the factors that influence objective cough counts in COPD. Cough may be a marker for progressive disease in milder COPD patients who continue to smoke, and it may be useful in case-finding for milder disease in the community. The cough reflex sensitivity is heightened in COPD compared with healthy volunteers and similar to that in subjects with asthma. The degree of airflow obstruction does not predict cough reflex sensitivity or objective cough counts, implying an independent process. Effective treatments for cough in COPD have not yet been identified. Improved outcome measures of cough, a better understanding of cough in the natural history of COPD, and its importance to patients are needed

Multiple perspectives on the attribution of the extreme European summer of 2012 to climate change

Summer 2012 was very wet in northern Europe, and unusually dry and hot in southern Europe. We use multiple approaches to determine whether anthropogenic forcing made the extreme European summer of 2012 more likely. Using a number of observation- and model-based methods, we find that there was an anthropogenic contribution to the extremes in southern Europe, with a qualitative consensus across all methodologies. There was a consensus across the methodologies that there has been a significant increase in the risk of hot summers in southern Europe with climate change. Most approaches also suggested a slight drying, but none of the results were statistically significant. The unusually wet summer in northern Europe was made more likely by the observed atmospheric circulation pattern in 2012, but no evidence was found for a long-term trend in circulation

Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin

In addition to their clinical utility in tissue transplantation the immunosuppressive agents FK-506 (Prograf) and rapamycin, have proven to be valuable tools for gaining insight into the biochemistry of T-cell activation. The findings that the protein phosphatase calcineurin and cell cycle control are key elements in T-cell activation and proliferation are the direct result of investigations into the mechanism of action of FK-506 and rapamycin and provide potentially novel therapeutic targets